Skip to main content
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1964 Oct;27(5):463–469. doi: 10.1136/jnnp.27.5.463

Clinical trial of methysergide and other preparations in the management of migraine

D A Curran 1,2,1, J W Lance 1,2
PMCID: PMC495777  PMID: 14213477

Full text

PDF
463

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHAPMAN L. F., RAMOS A. O., GOODELL H., SILVERMAN G., WOLFF H. G. A humoral agent implicated in vascular headache of the migraine type. Arch Neurol. 1960 Sep;3:223–229. doi: 10.1001/archneur.1960.00450030001001. [DOI] [PubMed] [Google Scholar]
  2. DALESSIO D. J., CAMP W. A., GOODELL H., WOLFF H. G. Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type. Arch Neurol. 1961 Mar;4:235–240. doi: 10.1001/archneur.1961.00450090001001. [DOI] [PubMed] [Google Scholar]
  3. DALESSIO D. J. On migraine headache: serotonin and serotonin antagonism. JAMA. 1962 Jul 28;181:318–321. [PubMed] [Google Scholar]
  4. DALSGAARD-NIELSEN T. [On the prophylactic treatment of migraine with deseril]. Praxis. 1960 Sep 8;49:867–868. [PubMed] [Google Scholar]
  5. ELKIND A. H., FRIEDMAN A. P., GROSSMAN J. CUTANEOUS BLOOD FLOW IN VASCULAR HEADACHES OF THE MIGRAINE TYPE. Neurology. 1964 Jan;14:24–30. doi: 10.1212/wnl.14.1.24. [DOI] [PubMed] [Google Scholar]
  6. FRIEDMAN A. P., LOSIN S. Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide). Arch Neurol. 1961 Mar;4:241–245. doi: 10.1001/archneur.1961.00450090007002. [DOI] [PubMed] [Google Scholar]
  7. FRIEDMAN A. P. Treatment of headache with reserpine. Neurology. 1955 Nov;5(11):805–808. doi: 10.1212/wnl.5.11.805. [DOI] [PubMed] [Google Scholar]
  8. GRAHAM J. R. Use of a new compound, UML-491 (1-methyl-D-lysergic acid butanolamide), in the prevention of various types of headache. N Engl J Med. 1960 Dec 22;263:1273–1277. doi: 10.1056/NEJM196012222632502. [DOI] [PubMed] [Google Scholar]
  9. HALE A. R., REED A. F. Prophylaxis of frequent vascular headache with methysergide. Am J Med Sci. 1962 Jan;243:92–98. doi: 10.1097/00000441-196201000-00014. [DOI] [PubMed] [Google Scholar]
  10. HARRIS M. C. Prophylactic treatment of migraine headache and histamine cephalalgia with a serotonin antagonist (methysergide). Ann Allergy. 1961 May;19:500–504. [PubMed] [Google Scholar]
  11. HAVERBACK B. J., DUTCHER T. F., SHORE P. A., TOMICH E. G., TERRY L. L., BRODIE B. B. Serotonin changes in platelets and brain induced by small daily doses of reserpine; lack of effect of depletion of platelet serotonin on hemostatic mechanisms. N Engl J Med. 1957 Feb 21;256(8):343–345. doi: 10.1056/NEJM195702212560804. [DOI] [PubMed] [Google Scholar]
  12. HEYCK H. [Serotonin antagonists in the therapy of migraine and Bing's erythroprosopalgia or the Horton syndrome]. Schweiz Med Wochenschr. 1960 Feb 27;90:203–209. [PubMed] [Google Scholar]
  13. KIMBALL R. W., FRIEDMAN A. P., VALLEJO E. Effect of serotonin in migraine patients. Neurology. 1960 Feb;10:107–111. doi: 10.1212/wnl.10.2.107. [DOI] [PubMed] [Google Scholar]
  14. LANCE J. W., FINE R. D., CURRAN D. A. An evaluation of methysergide in the prevention of migraine and other vascular headaches. Med J Aust. 1963 Jun 1;50(1):814–818. [PubMed] [Google Scholar]
  15. LUND F. Studies on the shape of the temporal artery pulsations in vascular headache, particularly migraine. Acta Med Scand. 1957 Jul 5;158(1):21–34. doi: 10.1111/j.0954-6820.1957.tb15739.x. [DOI] [PubMed] [Google Scholar]
  16. OSTFELD A. M., CHAPMAN L. F., GOODELL H., WOLFF H. G. Studies in headache; summary of evidence concerning a noxious agent active locally during migraine headache. Psychosom Med. 1957 May-Jun;19(3):199–208. doi: 10.1097/00006842-195705000-00005. [DOI] [PubMed] [Google Scholar]
  17. OSTFELD A. M., REIS D. J., GOODELL H., WOLFF H. G. Headache and hydration; the significance of two varieties of fluid accumulation in patients with vascular headache of the migraine type. AMA Arch Intern Med. 1955 Aug;96(2):142–152. doi: 10.1001/archinte.1955.00250130016002. [DOI] [PubMed] [Google Scholar]
  18. ROOKE E. D., RUSHTON J. G., PETERS G. A. Vasodilating headache: a suggested classification and results of prophylactic treatment with UML 491 (methysergide). Proc Staff Meet Mayo Clin. 1962 Aug 15;37:433–443. [PubMed] [Google Scholar]
  19. SCHOTTSTAEDT W. W., WOLFF H. G. Studies on headache; variations in fluid and electrolyte excretion in association with vascular headache of migraine type. AMA Arch Neurol Psychiatry. 1955 Feb;73(2):158–164. [PubMed] [Google Scholar]
  20. SELBY G., LANCE J. W. Observations on 500 cases of migraine and allied vascular headache. J Neurol Neurosurg Psychiatry. 1960 Feb;23:23–32. doi: 10.1136/jnnp.23.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. SICUTERI F. Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine. Int Arch Allergy Appl Immunol. 1959;15:300–307. doi: 10.1159/000229055. [DOI] [PubMed] [Google Scholar]
  22. SOUTHERN A. L., CHRISTOFF N. Cerebrospinal fluid serotonin in brain tumor and other neurological disorders determined by a spectrophotofluorometric technique. J Lab Clin Med. 1962 Feb;59:320–326. [PubMed] [Google Scholar]
  23. SOUTHWELL N., WILLIAMS J. D., MACKENZIE I. METHYSERGIDE IN THE PROPHYLAXIS OF MIGRAINE. Lancet. 1964 Mar 7;1(7332):523–524. doi: 10.1016/s0140-6736(64)92910-1. [DOI] [PubMed] [Google Scholar]
  24. TUNIS M. M., WOLFF H. G. Analysis of cranial artery pulse waves in patients with vascular headache of the migraine type. Am J Med Sci. 1952 Nov;224(5):565–568. doi: 10.1097/00000441-195211000-00013. [DOI] [PubMed] [Google Scholar]
  25. WOLFF H. G. Headache mechanisms. Int Arch Allergy Appl Immunol. 1955;7(4-6):210–278. doi: 10.1159/000228230. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES